MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
CTSQ (Cancer Therapy Satisfaction Questionnaire) PDF Print E-mail

Developed by:
Pfizer Inc. (USA)

Objective:
To assess satisfaction with and preference for chemotherapy treatment, and for biological therapy in either pill or IV form

Copyright:
CTSQ © 2007 Pfizer Inc. All rights reserved.

Reference publications:
Abetz L, Coombs JH, Keininger DL, Earle CC, Wade C, Bury-Maynard D,Copley-Merriman K, Hsu MA. Development of the cancer therapy satisfaction questionnaire: item generation and content validity testing. Value Health. 2005 Nov-Dec;8 Suppl 1:S41-53.

Trask PC, Tellefsen C, Espindle D, Getter C, & Hsu M-A. Psychometric validation of the Cancer Therapy Satisfaction Questionnaire (CTSQ). Value in Health (in press).

Conditions of use:

1. User Agreement:

carre6 Existing translations : user is required to complete and sign a User Agreement with Pfizer Inc. in which specific conditions required by Pfizer Inc. are detailed.
carre6 New translation(s): in addition to the User Agreement, user is required to complete and sign a Translation Agreement with Pfizer Inc.

2. Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge
- In funded academic research (2): 250 €* per study + 20 €* per language version
- In commercial studies (3) involving "for-profit" organizations: 550 €* per study + 70 €* per language 
   version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies)

Review copy:

Original US English version available for review purpose only. Please click here to access.

Contact information:

MAPI Research Trust
Christelle BERNE

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have two original copies of the User Agreement and/or Translation Agreement completed, dated and signed and return them both to MAPI Research Trust by post. As soon as we receive them, we will process your request.

More information on CTSQ on PROQOLID

[ BACK ]
 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org